Blood-borne Pathogens Routine Surveillance System Report

Volume: 28S2 • July 2002

Blood-borne Pathogens Routine
Surveillance System Report

28S2

Statistics and Risk Assessment Section
Health Care Acquired Infections Division
Centre for Infectious Disease Prevention and Control

July 2002

Blood-borne Pathogens Routine Surveillance System Report
71 Pages - 1,219 KB in PDF Format

Introduction | Table of Contents

Introduction

Welcome to the first annual report of the Blood-borne Pathogens Routine Surveillance System (BBPRSS), 2001. The following report, developed by the Statistics and Risk Assessment Section of the Health Care Acquired Infections Division (HCAID), Centre for Infectious Disease Prevention and Control, summarizes surveillance data collected from various data sources on blood-borne pathogens currently under investigation within the HCAID. The primary area of research and surveillance of the HCAID comprises pathogens transmitted by blood, including pathogens that can be transmitted through transfusion or shared needle use. The HCAID also conducts surveillance activities when blood-borne transmission is theoretical in nature (i.e. for Creutzfeldt-Jakob Disease).

The objective of the BBPRSS is to identify and estimate the burden of blood-borne diseases at a national level. Data contained within this report will aid and support researchers in formulating national and provincial policies for the prevention and control of blood-borne pathogens. The report is also intended to generate and stimulate additional etiologic research.

The first report of the BBPRSS provides descriptive epidemiologic and statistical information on the blood-borne pathogens under investigation, namely the following:

Hepatitis A
Hepatitis B
Non-A, non-B hepatitis
Hepatitis C (reported cases)
Creutzfeldt-Jakob Disease
Human T-cell lymphotropic virus I
Human T-cell lymphotropic virus II

The information presented in this report comes from a number of health data and surveillance sources, including the National Mortality Database, the Canadian Morbidity Database, the Notifiable Diseases Information Registry, the Enhanced Surveillance System for Hepatitis B and C, and the CJD Surveillance System. Additional information on the sources and methods, including limitations
inherent in the data, is provided on page 2. The surveillance data provided are essential for the Health Care Acquired Infections Division to accurately analyze and provide insight into nationwide trends and patterns, to identify populations at risk, and to determine potential sources of transmission of blood-borne pathogens.
BBPRSS aims to provide and disseminate information on blood-borne pathogen disease trends on a yearly basis. Additional supplemental reports may be generated throughout the year, focusing on specific blood-borne pathogens.

Introduction
Data Sources and Methods
	Mortality Morbidity Classification of Disease Notifiable Diseases Enhanced Hepatitis Surveillance Creutzfeldt-Jakob Disease Surveillance System Methods Population Data Orius
Hepatitis A - Reported Cases
	Major Findings
	Table 1.1	Reported Cases, Age Standardized Reported Rates and Crude Rates for Hepatitis A by Year, Canada, 1980-1999.
	Figure 1.1A	Reported Cases and Age Standardized Reported Rates for Hepatitis A by Year and Sex, Canada, 1980-1999
	Figure 1.1B	Reported Crude Rates for Hepatitis A by Age Group, Canada, 1980-1999
	Figure 1.1C	Reported Crude Rates for Hepatitis A by Province/ Territory and Sex, Canada, 1990-1999 .
	Figure 1.1D	Reported Crude Rates for Hepatitis A by Province/Territory, 1990-1999, Male and Female Combined
Hepatitis A - Morbidity
	Major Findings
	Table 1.2	Hospital Admissions and Age Standardized Hospitalization Rates for Hepatitis A by Year, Canada, 1980-1998
	Figure 1.2A	Age Standardized Hospitalization Rates for Hepatitis A by Hospital Admissions and Sex, Canada, 1980-1998
	Figure 1.2B	Age Standardized Hospitalization Rates for Hepatitis Aby Age Group, Canada, 1980-1998 Blood-borne Pathogens Routine Surveillance System
	Figure 1.2C	Age Standardized Hospitalization Rates for Hepatitis A by Province/Territory and Sex, Canada, 1989-1998
	Figure 1.2D	Age Standardized Hospitalization Rates for Hepatitis A by Province/Territory, 1989-1998, Male and Female Combined
Hepatitis A - Mortality
	Major Findings
	Table 1.3	Deaths and Age Standardized Mortality Rates for Hepatitis A by Year, Canada, 1980-1998
	Figure 1.3A	Age Standardized Mortality Rates for Hepatitis A by Sex, Canada, 1980-1998
	Figure 1.3B	Age Standardized Mortality Rates for Hepatitis A by Age Group, Canada, 1980-1998
	Figure 1.3C	Age Standardized Mortality Rates for Hepatitis A by Province/Territory and Sex, Canada, 1989-1998
Hepatitis B - Reported Cases
	Major Findings
	Table 2.1	Reported Cases, Age Standardized Reported Rates and Crude Rates for Hepatitis B by Year, Canada, 1980-1999
	Figure 2.1A	Reported Cases and Age Standardized Reported Rates for Hepatitis B by Year and Sex, Canada, 1980-1999
	Figure 2.1B	Reported Crude Rates for Hepatitis B by Age Group, Canada, 1980-1999
	Figure 2.1C	Reported Crude Rates for Hepatitis B by Province/Territory and Sex, Canada, 1990-1999
	Figure 2.1D	Reported Crude Rates for Hepatitis B by Province/Territory, 1990-1999, Male and Female Combined
Hepatitis B - Morbidity
	Major Findings
	Table 2.2	Hospital Admissions and Age Standardized Hospitalization Rates for Hepatitis B by Year, Canada, 1980-1998
	Figure 2.2A	Age Standardized Hospitalization Rates for Hepatitis B by Hospital Admissions and Sex, Canada, 1980-1998
	Figure 2.2B	Age Standardized Hospitalization Rates for Hepatitis B by Age Group, Canada, 1980-1998
	Figure 2.2C	Age Standardized Hospitalization Rates for Hepatitis B by Province/Territory and Sex, Canada, 1989-1998
	Figure 2.2D	Age Standardized Hospitalization Rates for Hepatitis B by Province/Territory, 1989-1998, Male and Female Combined
Hepatitis B - Mortality
	Major Findings
	Table 2.3	Deaths and Age Standardized Mortality Rates for Hepatitis B by Year, Canada, 1980-1998
	Figure 2.3A	Age Standardized Mortality Rates for Hepatitis B by Sex, Canada, 1980-1998
	Figure 2.3B	Age Standardized Mortality Rates for Hepatitis B by Age Group, Canada, 1980-1998
	Figure 2.3C	Age Standardized Mortality Rates for Hepatitis B by Province/Territory and Sex, Canada, 1989-1998
	Figure 2.3D	Age Standardized Mortality Rates for Hepatitis B by Province/Territory, 1989-1998, Male and Female Combined
Hepatitis C - Reported Cases
	Major Findings
	Table 3.1	Reported Cases, Age Standardized Reported Rates and Crude Rates for Hepatitis C by Year, Canada 1991-1999
	Figure 3.1A	Reported Cases and Age Standardized Reported Rates for Hepatitis C by Year and Sex, 1991-1999
	Figure 3.1B	Reported Crude Rates for Hepatitis C by Age Group, Canada, 1991-1999
	Figure 3.1C	Reported Crude Rates for Hepatitis C by Province/ Territory and Sex, Canada, 1991-1999
	Figure 3.1D	Reported Crude Rates for Hepatitis C by Province/ Territory, 1991-1999, Male and Female Combined
Non-A, Non-B Hepatitis - Morbidity
	Major Findings
	Table 3.2	Hospital Admissions and Age Standardized Hospitalization Rates for Non-A, Non-B Hepatitis by Year, Canada, 1980-1998
	Figure 3.2A	Age Standardized Hospitalization Rates for Non-A, Non-B Hepatitis by Hospital Admissions and Sex, Canada, 1980-1998
	Figure 3.2B	Age Standardized Hospitalization Rates for Non-A, Non-B Hepatitis by Age Group, Canada, 1980-1998
	Figure 3.2C	Age Standardized Hospitalization Rates for Non-A, Non-B Hepatitis by Province/Territory and Sex, Canada, 1989-1998
	Figure 3.2D	Age Standardized Hospitalization Rates for Non-A, Non-B Hepatitis by Province/Territory, 1989-1998, Male and Female Combined
Non-A, Non-B Hepatitis - Mortality
	Major Findings
	Table 3.3	Deaths and Age Standardized Mortality Rates for Non-A, Non-B Hepatitis by Year, Canada, 1980-1998
	Figure 3.3A	Age Standardized Mortality Rates for Non-A, Non-B Hepatitis by Sex, Canada, 1980-1998 .
	Figure 3.3B	Age Standardized Mortality Rates for Non-A, Non-B Hepatitis by Age Group, Canada, 1980-1998
	Figure 3.3C	Age Standardized Mortality Rates for Non-A, Non-B Hepatitis by Province/Territory and Sex, Canada, 1989-1998
	Figure 3.3D	Age Standardized Mortality Rates for Non-A, Non-B Hepatitis by Province/Territory, 1989-1998, Male and Female Combined
Creutzfeldt-Jakob Disease - Reported Cases Creutzfeldt-Jakob Disease - Morbidity
	*Major Findings*
	Table 4.1	Hospital Admissions and Age Standardized Hospitalization Rates for CJD by Year, Canada, 1980-1998
	Figure 4.1A	Age Standardized Hospitalization Rates for CJD by Hospital Admissions and Sex, Canada, 1980-1998
	Figure 4.1B	Age Standardized Hospitalization Rates for CJD by Age Group, Canada 1980-1998
	Figure 4.1C	Age Standardized Hospitalization Rates for CJD by Province/Territory and Sex, Canada, 1989-1998
	Figure 4.1D	Age Standardized Hospitalization Rates for CJD by Province/Territory, 1989-1998, Male and Female Combined
Creutzfeldt-Jakob Disease - Mortality
	Major Findings
	Table 4.2	Deaths and Age Standardized Mortality Rates for CJD by Year, Canada, 1980-1998
	Figure 4.2A	Age Standardized Mortality Rates for CJD by Sex, Canada, 1980-1998
	Figure 4.2B	Age Standardized Mortality Rates for CJD by Age Group, Canada, 1980-1998
	Figure 4.2C	Age Standardized Mortality Rates for CJD by Province/ Territory and Sex, Canada, 1989-1998
	Figure 4.2D	Age Standardized Mortality Rates for CJD by Province/Territory, 1989-1998, Male and Female Combined
Human T-cell Lymphotropic Virus (HTLV) - Morbidity
	Major Findings
	Table 5.1	Hospital Admissions and Age Standardized Hospitalization Rates for HTLV by Year, Canada, 1994-1999
	Figure 5.1A	Age Standardized Hospitalization Rates for HTLV by Hospital Admissions and Sex, Canada, 1994-1999
	Figure 5.1B	Age Standardized Hospitalization Rates for HTLV by Age Group, Canada 1994-1999
	Figure 5.1C	Age Standardized Hospitalization Rates for HTLV by Province/ Territory and Sex, Canada, 1994-1999
Enhanced Surveillance for Acute Hepatitis B and C Infections
	Introduction Sentinel Surveillance Sites
Hepatitis B - Enhanced Data
	Major Findings
	Table 6.1	Cases and Crude Rates for Hepatitis B by Age Group,Sex Combined, Canada, 1999 and 2000
	Figure 6.1A	Cases and Crude Rates for Hepatitis B by Age Group and Sex, Canada, 1999 and 2000
	Figure 6.1B	Hepatitis B Mutually Exclusive Risk Factors, 1999
	Figure 6.1C	Hepatitis B Mutually Exclusive Risk Factors, 2000
Hepatitis C - Enhanced Data
	Major Findings
	Table 6.2	Cases and Crude Rates for Hepatitis C by Age Group, Sex Combined, Canada, 1999 and 2000
	Figure 6.2A	Cases and Crude Rates for Hepatitis C by Age Group, Sex, Canada, 1999 and 2000
	Figure 6.2B	Hepatitis C Mutually Exclusive Risk Factors, 1999
	Figure 6.2C	Hepatitis C Mutually Exclusive Risk Factors, 2000
Average Annual Percent Change (AAPC)
	Major Findings in Reported Cases
	Table 7.1	AAPC in Age-Standardized Reported Cases, Morbidity and Mortality Rates for Blood-borne Pathogens
	Figure 7.1	AAPC for Reported Cases of Selected Diseases by Sex, Canada, 1990-1999 Major Findings in Mortality and Morbidity: Males
	Table 7.2	AAPC Rates for Males, Canada, 1989-1998
	Figure 7.2	AAPC for Mortality and Morbidity Rates of Selected Diseases, Males, Canada, 1989-1998 Major Findings in Mortality and Morbidity: Females
	Table 7.3	AAPC Rates for Females, Canada, 1989-1998
	Figure 7.3	AAPC for Mortality and Morbidity Rates of Selected Diseases, Females, Canada, 1989-1998
References

Blood-borne Pathogens Routine Surveillance System Report
71 Pages - 1,219 KB in PDF Format


	Last Updated: 2002-09-26		Important Notices